Home Healthcare IT Asia Pacific Neurodegenerative Diseases Market Size, Share & Analysis 2031

Asia Pacific Neurodegenerative Disease Market Size, Share & Trends Analysis Report By Indication Type (Parkinson's Disease, Alzheimer's Disease, Multiple Sclerosis, Huntington Disease, Other Indication Types), By Drug Type (N-methyl-D-aspartate Receptor antagonists, Cholinesterase Inhibitors, Dopamine Agonists, Immunomodulatory Drugs, Other Drug Types) and By Country(China, Korea, Japan, India, Australia, Taiwan, South East Asia, Rest of Asia-Pacific) Forecasts, 2024-2032

Report Code: SRHI3157DR
Last Updated : Jan 08, 2024
Author : Straits Research
Starting From
USD 1850
Buy Now

Market Segmentation

  • Asia Pacific Neurodegenerative Disease Market, By Indication Type (2020-2030)
    1. Parkinson's Disease
    2. Alzheimer's Disease
    3. Multiple Sclerosis
    4. Huntington Disease
    5. Amyotrophic Lateral Sclerosis
    6. Spinal Muscular Atrophy (SMA) 
    7. Other Indication Types
  • Asia Pacific Neurodegenerative Disease Market, By Drug Type (2020-2030)
    1. N-methyl-D-aspartate Receptor antagonists
    2. Cholinesterase Inhibitors
    3. Dopamine Agonists
    4. Immunomodulatory Drugs
    5. Acetylcholinesterase (AChE) Inhibitors
    6. Antagonist, Monoamine Oxidase B (MAO-B) Inhibitor
    7. Catechol-O-Methyltransferase (COMT) Inhibitor
    8. SSRIs
    9. Other Drug Types

    Related Reports

    Global Report
    Regenerative Medicine Market Size The global regenerative medicine market size is estimated to be worth USD 19.80 billion in 2024 and is projected to reach from USD 24.88 billion in 2025 to USD 148.42 billion by 2033, growing at
    Buy Now

    Purchase Benefits

    • Eligible for a free updated report next year
    • Completely customizable scope
    • 30% discount on your next purchase
    • Dedicated account manager
    • Query resolution within 24 hours
    • Permission to print the report


    We are featured on :